View in EDS HTML Full Text PDF Full Text

Pharmacokinetic, efficacy and safety evaluation of B‐domain‐deleted recombinant FVIII (SCT800) for prophylactic treatment in adolescent and adult patients with severe haemophilia A.

Saved in:
Bibliographic Details
Title: Pharmacokinetic, efficacy and safety evaluation of B‐domain‐deleted recombinant FVIII (SCT800) for prophylactic treatment in adolescent and adult patients with severe haemophilia A.
Authors: Xue, Feng1 (AUTHOR), Zhao, Xielan2 (AUTHOR), Sun, Jing3 (AUTHOR), Zeng, Xiaojing4 (AUTHOR), Yang, Fenge5 (AUTHOR), Xu, Ming6 (AUTHOR), Yu, Ziqiang7 (AUTHOR), Gu, Weiying8 (AUTHOR), Feng, Ying9 (AUTHOR), Li, Wenqian10 (AUTHOR), Zheng, Changcheng11 (AUTHOR), Bi, Hui12 (AUTHOR), Xie, Liangzhi13 (AUTHOR), Gai, Wenlin13 (AUTHOR), Yang, Renchi1 (AUTHOR) rcyang65@163.com
Source: Haemophilia. Sep2021, Vol. 27 Issue 5, p814-822. 9p. 1 Diagram, 5 Charts, 1 Graph.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:13518216
DOI:10.1111/hae.14350